Statement of Retraction: Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway.

IF 4.2 4区生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Bioengineered Pub Date : 2024-12-01 Epub Date: 2024-02-20 DOI:10.1080/21655979.2024.2299585

引用次数: 0

查看原文本刊更多论文

撤回声明：蛋白酪氨酸磷酸酶受体Z1型通过调节PI3K/AKT/mTOR信号通路抑制卵巢癌的顺铂耐药性

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bioengineered BIOTECHNOLOGY & APPLIED MICROBIOLOGY-

CiteScore

8.20

自引率

28.60%

发文量

1114

审稿时长

17 weeks

期刊介绍： Bioengineered provides a platform for publishing high quality research on any aspect of genetic engineering which involves the generation of recombinant strains (both prokaryote and eukaryote) for beneficial applications in food, medicine, industry, environment and bio-defense.